相关实验视频
Updated: May 16, 2025
08:20
Genome Engineering of Primary Human B Cells Using CRISPR/Cas9
Published on: November 3, 2020
6.2K
临床相关血型系统的CRISPR-Cas9驱动的抗原转化
Yelena Boccacci1,2,3,4, Nellie Dumont4, Yannick Doyon1,2,3
1Centre Hospitalier Universitaire de Québec Research Center - Université Laval, 2705 boulevard Laurier, Québec, QC G1V 4G2, Canada.
Human molecular genetics
|April 2, 2025
概括
基因编辑创造了通用捐赠者血细胞. 培养红细胞 (cRBC) 的这一突破可以克服血型不相容性,并扩大罕见血型患者的输血选择.
科学领域:
- 再生医学是一种再生医学.
- 血液学 血液学 血液学
- 基因编辑技术的技术
背景情况:
- 输血依赖于兼容的血液类型,由于抗原的多样性,很难找到这些血液类型.
- 长期输血的患者面临来自外来红细胞 (RBC) 的重复暴露的免疫风险.
- 由于其免疫性和多态性,ABO和 rhesus (Rh) 血型系统在输血医学中至关重要.
研究的目的:
- 研究培养红细胞 (cRBC) 与基因编辑相结合的潜力,以应对输血挑战.
- 开发一种生产抗原阴性红细胞的方法,以改善输血可访问性.
主要方法:
- 利用CRISPR-Cas9基因编辑来淘汰负责血液造血干细胞和祖细胞 (HSPC) 中AB和Rh抗原表达的基因.
- 在基因编辑中采用无病毒和无选择的方法.
- 培养编辑的HSPCs产生红状腺细胞 (cRBC).
主要成果:
- 在工程化cRBC中实现了几乎完全转换为O和RhNull表型.
- 使用标准血凝和流细胞计验证了表型变化.
- 证明了生产抗原阴性cRBCs的可行性.
结论:
- 通过CRISPR-Cas9基因编辑,可以有效地从cRBC中消除AB和Rh抗原.
- 这种方法有望扩大对未满足需求的患者的输血可用性,特别是那些需要罕见血型的患者.
- 将基因编辑cRBC与现有协议结合起来,可能会彻底改变输血医学.
相关概念视频
01:59CRISPR
48.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.6K
02:45Blood Transfusion and Agglutination
10.6K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.6K
01:10Blood Typing
1.0K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.0K